iPro 2 Professional Evaluation CGM SYSTEM
An iPro®2 evaluation reveals glucose fluctuations that A1C tests and finger sticks can miss.
PRODUCT DETAILS
The iPro2 Professional CGM evaluation uses a small, lightweight, and watertight continuous glucose monitor (CGM) to record your glucose readings every five minutes. This can give your healthcare provider insights into how your diet, medication, and daily activities really affect your glucose levels.
WHAT TO EXPECT
- Your healthcare professional will help you get set up in minutes with a sensor and a connected iPro recorder to wear for six to seven days.
- During these six to seven days, you can go about your everyday life while wearing the device.
- When you return the sensor to your doctor, he or she will download the data and analyze the CGM results to give you a personalized report.
KEY FEATURES
GET A MORE COMPLETE PICTURE
An iPro2 Professional CGM evaluation helps you learn what works for you so that you can better control your diabetes.
With iPro2, you can:
- Learn how meals, daily activity and sleep can change your glucose levels.
- Get on the same page with your doctor regarding your diabetes management.
GAIN INSIGHTS INTO SPENDING MORE TIME iN RANGE
Therapy adjustments made with CGM data have been proven to:
- Reduce the frequency and duration of highs and lows 1,2
- Reduce A1C levels, which can lead to reduced risk of complications 3,4
1
Kaufman FR, Gibson LC, Halvorson M, et al. A pilot study of the continuous glucose monitoring system. Diabetes Care. 2001;24(12):2030-2034.
2
Battelino T, Conget I, Olsen B, et al; and SWITCH Study Group. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012:55:3155-3162.
3
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med. 1993;329(14):977-986.
4
Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311-320.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.
